Drug Design, Development and Therapy, 2024 · DOI: https://doi.org/10.2147/DDDT.S463177 · Published: April 29, 2024
Hydrogen, a novel biomedical molecule, is being researched for its anti-inflammatory, antioxidant, and antiapoptotic effects, showing promise in treating various diseases, including spinal cord injury. This review explores the potential molecular mechanisms of hydrogen therapy in treating spinal cord injury, aiming to understand its medical value and offer new options for adjuvant treatment. Hydrogen is now recognized as being the fourth signaling gas molecule after Nitric Oxide (NO), Carbon monoxide (CO), and Hydrogen sulfide (H2S) and is considered a novel medical gas molecule.
Hydrogen therapy may provide new avenues for the adjuvant treatment of SCI.
Findings from basic and preclinical studies may translate into new conventional treatments for SCI.
Further research is needed to explore the possibility of using hydrogen as a diagnostic biomarker for SCI.